The effect of cladribine on some parameters of blood and cerebrospinal fluid in patients with relapsing-remitting multiple sclerosis (RR-MS).
Stelmasiak
Z
Z
Katedra i Klinika Neurologii Akademii Medycznej w Lublinie.
Bartosik-Psujek
H
H
Belniak-Legieć
E
E
Mitosek-Szewczyk
K
K
D000328:Adult; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis*; D017338:Cladribine / Q000494:pharmacology*; D005260:Female; D006098:Granulocytes / Q000187:drug effects; D006801:Humans; D007279:Injections, Subcutaneous; D007677:Kidney Function Tests; D007958:Leukocyte Count; D008111:Liver Function Tests; D018655:Lymphocyte Count; D008297:Male; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000097:blood* / Q000134:cerebrospinal fluid / Q000188:drug therapy* / Q000503:physiopathology
D002556:Cerebrospinal Fluid Proteins; D017338:Cladribine